Learn More
Medchemexpress LLC Rg-12525 | 120128-20-3 | 98.3% | 423.47 g/mol | C25H21N5O2 | 25 MG

Supplier: Medchemexpress LLC HY10167625MG
RG-12525 is a small-molecule research compound reported as a potent antagonist of peptidoleukotrienes (LTC4, LTD4, LTE4); it also shows PPAR-gamma agonist activity and inhibits CYP3A4. Intended for in vitro and preclinical studies, the compound is supplied at high purity and is typically dissolved in DMSO for assays.
- Specific antagonist of peptidoleukotrienes with low-nanomolar activity
- Shows PPAR-gamma agonist activity (approx. IC50 60 nM)
- Inhibits CYP3A4 (Ki ≈ 0.5 μM)
- High purity suitable for preclinical research
- Soluble in DMSO for assay preparation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.